Der Standort Med Campus IV. des Kepler Universitätsklinikums in Linz wurde bis 2016 als Landes- Frauen- und Kinderklinik Linz geführt. Das Krankenhaus befindet sich im Neustadtviertel.

During the past decade, Landes Frauen Und Kinderklinik Linz conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Landes Frauen Und Kinderklinik Linz" #1 sponsor was "Baxalta now part of Shire" with 2 trials, followed by "Actelion" with 1 trials sponsored, "Canadian Cancer Trials Group" with 1 trials sponsored, "Guerbet" with 1 trials sponsored and "Instituto de Investigacion Sanitaria La Fe" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Landes Frauen Und Kinderklinik Linz" #1 collaborator was "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom Germany" with 1 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator, "Belgium Gynecologic Oncology Group" with 1 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Landes Frauen Und Kinderklinik Linz" are "Hemophilia A" (2 trials), "Cervical Cancer" (1 trials), "LOW AND INTERMEDIATE PAEDIATRIC NEUROBLASTOMA AND NEONATAL SUPRARENAL MASSES" (1 trials), "Magnetic Resonance Imaging" (1 trials) and "Pulmonary Arterial Hypertension" (1 trials). Many other conditions were trialed in "Landes Frauen Und Kinderklinik Linz" in a lesser frequency.

Most popular intervention types in "Landes Frauen Und Kinderklinik Linz" are "Drug" (3 trials), "Biological" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method" (1 trials), "BAX855" (1 trials), "DOTAREM" (1 trials), "Macitentan" (1 trials) and "PEGylated Recombinant Factor VIII" (1 trials). Other intervention names were less common.

The vast majority of trials in "Landes Frauen Und Kinderklinik Linz" are 4 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Landes Frauen Und Kinderklinik Linz". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Landes Frauen Und Kinderklinik Linz, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Landes Frauen Und Kinderklinik Linz, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".